Yehuda Carmeli
Impact in
- Molecular Medicine top 0.01%
- Antibiotic Resistance in Bacteria
- Applied Microbiology and Biotechnology top 0.01%
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Use and Resistance 84
-
- Antibiotic Resistance in Bacteria 203
- Co-authors
- Mitchell J. SchwaberShiri Navon‐VeneziaChristian G. GiskeMatthew H. SamoreDominique L. MonnetArjun SrinivasanStéphan HarbarthSara E. Cosgrove
- Journals
- Antimicrobial Agents and Chemotherapy (41 papers)Infection Control and Hospital Epidemiology (31 papers)Clinical Infectious Diseases (28 papers)Clinical Microbiology and Infection (24 papers)Journal of Antimicrobial Chemotherapy (20 papers)
- Partner nations
- IsraelUnited StatesFrance
In The Last Decade
Yehuda Carmeli
326 papers receiving 33.1k citations
Hit Papers
Peers
Comparison fields: 5 of 186
- Molecular Medicine 20.0k
- Applied Microbiology and Biotechnology 7.8k
- Endocrinology 6.6k
- Clinical Biochemistry 7.0k
- Critical Care and Intensive Care Medicine 2.5k
Countries citing papers authored by Yehuda Carmeli
This map shows the geographic impact of Yehuda Carmeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yehuda Carmeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yehuda Carmeli more than expected).
Fields of papers citing papers by Yehuda Carmeli
This network shows the impact of papers produced by Yehuda Carmeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yehuda Carmeli. The network helps show where Yehuda Carmeli may publish in the future.
Co-authors
The 25 scholars most cited alongside Yehuda Carmeli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 20 | |
| 5 | 2020 | 16 | |
| 6 | 2019 | 14 | |
| 7 | Revitalizing the antibiotic pipeline: Stimulating innovation while driving sustainable use and global access | 2018 | 33 |
| 8 | 2017 | 7 | |
| 9 | 2017 | 5 | |
| 10 | 2015 | 23 | |
| 11 | 2014 | 86 | |
| 12 | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Hit paper breakdown → | 2011 | 10072 |
| 13 | 2009 | 423 | |
| 14 | 2009 | 60 | |
| 15 | 2009 | 31 | |
| 16 | 2008 | 143 | |
| 17 | 2008 | 160 | |
| 18 | 2007 | 498 | |
| 19 | 2006 | 328 | |
| 20 | Adverse Clinical and Economic Outcomes Attributable to Methicillin Resistance among Patients withStaphylococcus aureusSurgical Site Infection Hit paper breakdown → | 2003 | 723 |
About Yehuda Carmeli
Yehuda Carmeli is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Endocrinology, Clinical Biochemistry and Infectious Diseases, having authored 332 papers that have together received 34.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (203 papers), Antibiotic Use and Resistance (84 papers), Bacterial Identification and Susceptibility Testing (71 papers), Antimicrobial Resistance in Staphylococcus (68 papers), Antibiotics Pharmacokinetics and Efficacy (62 papers), Enterobacteriaceae and Cronobacter Research (42 papers), Urinary Tract Infections Management (30 papers) and Vibrio bacteria research studies (29 papers). The work is most often cited by research in Molecular Medicine (20.0k citations), Applied Microbiology and Biotechnology (7.8k citations), Endocrinology (6.6k citations), Clinical Biochemistry (7.0k citations) and Critical Care and Intensive Care Medicine (2.5k citations). Yehuda Carmeli has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Mitchell J. Schwaber, Shiri Navon‐Venezia, Christian G. Giske, Matthew H. Samore, Dominique L. Monnet, Arjun Srinivasan, Stéphan Harbarth, Sara E. Cosgrove, Alkiviadis Vatopoulos and Janet Hindler. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Infection Control and Hospital Epidemiology, Clinical Infectious Diseases, Clinical Microbiology and Infection and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.